Vestbo Jørgen

Top coauthors of Vestbo Jørgen

Lange Peter (44 papers)

Calverley Peter M A (31 papers)

Tal-Singer Ruth (30 papers)

Lomas David A (27 papers)

Silverman Edwin K (25 papers)

List of Vestbo Jørgen publications

2018

Ronit Andreas, Lundgren Jens, Afzal Shoaib, Benfield Thomas, Roen Ashley, et al. 2018. "Airflow limitation in people living with HIV and matched uninfected controls." Thorax doi:10.1136/thoraxjnl-2017-211079

2017

Leeming Diana J, Byrjalsen Inger, Sand Jannie M B, Bihlet Asger R, Lange Peter, et al. 2017. "Biomarkers of collagen turnover are related to annual change in FEV1 in patients with chronic obstructive pulmonary disease within the ECLIPSE study." BMC pulmonary medicine 17 (1) doi:10.1186/s12890-017-0505-4
Woodcock Ashley, Vestbo Jørgen, Bakerly Nawar Diar, New John, Gibson J Martin, et al. 2017. "Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial." Lancet (London, England) 390 (10109) doi:10.1016/S0140-6736(17)32397-8
Plesner Louis Lind, Dalsgaard Morten, Schou Morten, Køber Lars, Vestbo Jørgen, et al. 2017. "The prognostic significance of lung function in stable heart failure outpatients." Clinical cardiology 40 (11) doi:10.1002/clc.22802
Crim Courtney, Calverley Peter M A, Anderson Julie A, Holmes Andrew P, Kilbride Sally, et al. 2017. "Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial." Respiratory medicine 131 doi:10.1016/j.rmed.2017.07.060
Brook Robert D, Anderson Julie A, Calverley Peter Ma, Celli Bartolome R, Crim Courtney, et al. 2017. "Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk." Heart (British Cardiac Society) 103 (19) doi:10.1136/heartjnl-2016-310897
Ronit Andreas, Kristensen Thomas, Klitbo Ditte M, Gelpi Marco, Kalhauge Anna, et al. 2017. "Incidental lung cancers and positive computed tomography images in people living with HIV." AIDS (London, England) 31 (14) doi:10.1097/QAD.0000000000001600
Wedzicha Jadwiga A, Calverley Peter M A, Albert Richard K, Anzueto Antonio, Criner Gerard J, et al. 2017. "Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline." The European respiratory journal 50 (3) doi:10.1183/13993003.02265-2016
Sivapalan Pradeesh, Moberg Mia, Eklöf Josefin, Janner Julie, Vestbo Jørgen, et al. 2017. "A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol." BMC pulmonary medicine 17 (1) doi:10.1186/s12890-017-0458-7
Calverley Peter M A, Anderson Julie A, Brook Robert D, Crim Courtney, Gallot Natacha, et al. 2017. "Fluticasone Furoate, Vilanterol and Lung Function Decline in Patients with Moderate COPD and Heightened Cardiovascular Risk." American journal of respiratory and critical care medicine doi:10.1164/rccm.201610-2086OC
Busch Robert, Hobbs Brian D, Zhou Jin, Castaldi Peter J, McGeachie Michael J, et al. 2017. "Genetic Association and Risk Scores in a Chronic Obstructive Pulmonary Disease Meta-analysis of 16,707 Subjects." American journal of respiratory cell and molecular biology 57 (1) doi:10.1165/rcmb.2016-0331OC
Vestbo Jørgen, Papi Alberto, Corradi Massimo, Blazhko Viktor, Montagna Isabella, et al. 2017. "Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial." Lancet (London, England) 389 (10082) doi:10.1016/S0140-6736(17)30188-5
Ravi Arjun K, Plumb Jonathan, Gaskell Rosemary, Mason Sarah, Broome Caroline S, et al. 2017. "COPD monocytes demonstrate impaired migratory ability." Respiratory research 18 (1) doi:10.1186/s12931-017-0569-y
Çolak Yunus, Afzal Shoaib, Nordestgaard Børge G, Vestbo Jørgen, Lange Peter 2017. "Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study." The Lancet. Respiratory medicine 5 (5) doi:10.1016/S2213-2600(17)30119-4
Reilev Mette, Lykkegaard Jesper, Halling Anders, Vestbo Jørgen, Søndergaard Jens, Pottegård Anton 2017. "Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study." NPJ primary care respiratory medicine 27 (1) doi:10.1038/s41533-017-0029-7
Vedel-Krogh Signe, Fallgaard Nielsen Sune, Lange Peter, Vestbo Jørgen, Nordestgaard Børge Grønne 2017. "Association of Blood Eosinophil and Blood Neutrophil Counts with Asthma Exacerbations in the Copenhagen General Population Study." Clinical chemistry 63 (4) doi:10.1373/clinchem.2016.267450
Vogelmeier Claus F, Criner Gerard J, Martinez Fernando J, Anzueto Antonio, Barnes Peter J, et al. 2017. "Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary." Respirology (Carlton, Vic.) 22 (3) doi:10.1111/resp.13012
Wedzicha Jadwiga A, Miravitlles Marc, Hurst John R, Calverley Peter M A, Albert Richard K, et al. 2017. "Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline." The European respiratory journal 49 (3) doi:10.1183/13993003.00791-2016
Vogelmeier Claus F, Criner Gerard J, Martínez Fernando J, Anzueto Antonio, Barnes Peter J, et al. 2017. "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary." Archivos de bronconeumologia 53 (3) doi:10.1016/j.arbres.2017.02.001
Hobbs Brian D, de Jong Kim, Lamontagne Maxime, Bossé Yohan, Shrine Nick, et al. 2017. "Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis." Nature genetics 49 (3) doi:10.1038/ng.3752
Vogelmeier Claus F, Criner Gerard J, Martinez Fernando J, Anzueto Antonio, Barnes Peter J, et al. 2017. "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary." The European respiratory journal 49 (3) doi:10.1183/13993003.00214-2017
Vogelmeier Claus F, Criner Gerard J, Martinez Fernando J, Anzueto Antonio, Barnes Peter J, et al. 2017. "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary." American journal of respiratory and critical care medicine 195 (5) doi:10.1164/rccm.201701-0218PP
Dalsgaard Morten, Plesner Louis Lind, Schou Morten, Kjøller Erik, Vestbo Jørgen, Iversen Kasper 2017. "Prevalence of airflow obstruction in patients with stable systolic heart failure." BMC pulmonary medicine 17 (1) doi:10.1186/s12890-016-0351-9
Singh Dave, Corradi Massimo, Spinola Monica, Papi Alberto, Usmani Omar S, et al. 2017. "Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide." International journal of chronic obstructive pulmonary disease 12 doi:10.2147/COPD.S146822
Mathioudakis Alexander G, Chatzimavridou-Grigoriadou Victoria, Corlateanu Alexandru, Vestbo Jørgen 2017. "Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis." European respiratory review : an official journal of the European Respiratory Society 26 (143) doi:10.1183/16000617.0073-2016
Dollerup Jens, Vestbo Jørgen, Murray-Thomas Tarita, Kaplan Alan, Martin Richard J, et al. 2017. "Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study." Clinical epidemiology 9 doi:10.2147/CLEP.S127775

2016

Jensen Jens-Ulrik S, Itenov Theis S, Thormar Katrin M, Hein Lars, Mohr Thomas T, et al. 2016. "Prediction of non-recovery from ventilator-demanding acute respiratory failure, ARDS and death using lung damage biomarkers: data from a 1200-patient critical care randomized trial." Annals of intensive care 6 (1) doi:10.1186/s13613-016-0212-y
Ronit Andreas, Haissman Judith, Kirkegaard-Klitbo Ditte Marie, Kristensen Thomas Skårup, Lebech Anne-Mette, et al. 2016. "Copenhagen comorbidity in HIV infection (COCOMO) study: a study protocol for a longitudinal, non-interventional assessment of non-AIDS comorbidity in HIV infection in Denmark." BMC infectious diseases 16 (1) doi:10.1186/s12879-016-2026-9
Martinez Fernando J, Vestbo Jørgen, Anderson Julie A, Brook Robert D, Celli Bartolome R, et al. 2016. "Effect of Fluticasone Furoate and Vilanterol on Exacerbations of COPD in Patients with Moderate Airflow Obstruction." American journal of respiratory and critical care medicine doi:10.1164/rccm.201607-1421OC
Kunisaki Ken M, Niewoehner Dennis E, Collins Gary, Aagaard Bitten, Atako Nafisah B, et al. 2016. "Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial." The Lancet. Respiratory medicine doi:10.1016/S2213-2600(16)30319-8
Sand Jannie M B, Leeming Diana J, Byrjalsen Inger, Bihlet Asger R, Lange Peter, et al. 2016. "High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study." Respiratory research 17 (1) doi:10.1186/s12931-016-0440-6
Andrianopoulos Vasileios, Celli Bartolome R, Franssen Frits M E, Pinto-Plata Victor M, Calverley Peter M A, et al. 2016. "Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study." Respiratory medicine 119 doi:10.1016/j.rmed.2016.08.023
Rodriguez-Roisin Roberto, Han MeiLan K, Vestbo Jørgen, Wedzicha Jadwiga A, Woodruff Prescott G, Martinez Fernando J 2016. "Chronic Respiratory Symptoms with Normal Spirometry: A Reliable Clinical Entity?" American journal of respiratory and critical care medicine doi:10.1164/rccm.201607-1376PP
Vestbo Jørgen, Leather David, Diar Bakerly Nawar, New John, Gibson J Martin, et al. 2016. "Effectiveness of Fluticasone Furoate-Vilanterol for COPD in Clinical Practice." The New England journal of medicine doi:10.1056/NEJMoa1608033
Singh Dave, Papi Alberto, Corradi Massimo, Pavlišová Ilona, Montagna Isabella, et al. 2016. "Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial." Lancet (London, England) 388 (10048) doi:10.1016/S0140-6736(16)31354-X
Topp Marie, Vestbo Jørgen, Mortensen Erik Lykke 2016. "Psychometric Properties of the COPD-Specific Beliefs About Medicine Questionnaire in an Outpatient Population: A Rasch-Analysis." Chronic obstructive pulmonary diseases (Miami, Fla.) 3 (4) doi:10.15326/jcopdf.3.4.2016.0134
Al-Shair Khaled, Kolsum Umme, Singh Dave, Vestbo Jørgen 2016. "The Effect of Fatigue and Fatigue Intensity on Exercise Tolerance in Moderate COPD." Lung doi:10.1007/s00408-016-9931-y
Lipworth Brian, Wedzicha Jadwiga, Devereux Graham, Vestbo Jørgen, Dransfield Mark T 2016. "Beta-blockers in COPD: time for reappraisal." The European respiratory journal doi:10.1183/13993003.01847-2015
Vestbo Jørgen 2016. "Natural experiments and large databases in respiratory and cardiovascular disease." European respiratory review : an official journal of the European Respiratory Society 25 (140) doi:10.1183/16000617.0028-2016
Plesner Louis L, Schoos Mikkel M, Dalsgaard Morten, Goetze Jens P, Kjøller Erik, et al. 2016. "Iron Deficiency in COPD Associates with Increased Pulmonary Artery Pressure Estimated by Echocardiography." Heart, lung & circulation doi:10.1016/j.hlc.2016.04.020
Wedzicha Jadwiga A, Banerji Donald, Chapman Kenneth R, Vestbo Jørgen, Roche Nicolas, et al. 2016. "Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD." The New England journal of medicine doi:10.1056/NEJMoa1516385
Karch Annika, Vogelmeier Claus, Welte Tobias, Bals Robert, Kauczor Hans-Ulrich, et al. 2016. "The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline." Respiratory medicine 114 doi:10.1016/j.rmed.2016.03.008
Vestbo Jørgen, Anderson Julie A, Brook Robert D, Calverley Peter M A, Celli Bartolome R, et al. 2016. "Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial." Lancet (London, England) 387 (10030) doi:10.1016/S0140-6736(16)30069-1
Topp Marie, Vestbo Jørgen, Mortensen Erik Lykke 2016. "Personality Traits and Mental Symptoms are Associated with Impact of Chronic Obstructive Pulmonary Disease on Patients' Daily life." COPD doi:10.3109/15412555.2016.1168793
Lange Peter, Çolak Yunus, Ingebrigtsen Truls Sylvan, Vestbo Jørgen, Marott Jacob Louis 2016. "Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis." The Lancet. Respiratory medicine doi:10.1016/S2213-2600(16)00098-9
Rabinovich Roberto A, Miller Bruce E, Wrobel Karolina, Ranjit Kareshma, Williams Michelle C, et al. 2016. "Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD." The European respiratory journal doi:10.1183/13993003.01824-2015
Agusti Alvar, Bel Elisabeth, Thomas Mike, Vogelmeier Claus, Brusselle Guy, et al. 2016. "Treatable traits: toward precision medicine of chronic airway diseases." The European respiratory journal 47 (2) doi:10.1183/13993003.01359-2015
Ronit Andreas, Klitbo Ditte Marie, Kildemoes Anna Overgaard, Benfield Thomas, Gerstoft Jan, et al. 2016. "Absence of Pneumocystis jirovecii Colonization in Human Immunodeficiency Virus-Infected Individuals With and Without Airway Obstruction and With Undetectable Viral Load." Open forum infectious diseases 3 (1) doi:10.1093/ofid/ofw044
Vestbo Jørgen, Lange Peter 2016. "Natural history of COPD: Focusing on change in FEV1." Respirology (Carlton, Vic.) 21 (1) doi:10.1111/resp.12589
Plesner Louis L, Warming Peder E, Nielsen Ture L, Dalsgaard Morten, Schou Morten, et al. 2016. "Chronic obstructive pulmonary disease in patients with end-stage kidney disease on hemodialysis." Hemodialysis international. International Symposium on Home Hemodialysis 20 (1) doi:10.1111/hdi.12342
Christiansen Anders, Davidsen Jesper Rømhild, Titlestad Ingrid, Vestbo Jørgen, Baumbach Jan 2016. "A systematic review of breath analysis and detection of volatile organic compounds in COPD." Journal of breath research 10 (3) doi:10.1088/1752-7155/10/3/034002

2015

Vedel-Krogh Signe, Nielsen Sune F, Lange Peter, Vestbo Jørgen, Nordestgaard Børge G 2015. "Blood Eosinophils and Exacerbations in COPD: the Copenhagen General Population Study." American journal of respiratory and critical care medicine doi:10.1164/rccm.201509-1869OC
Ingebrigtsen Truls S, Marott Jacob L, Lange Peter, Hallas Jesper, Nordestgaard Børge G, Vestbo Jørgen 2015. "Medically treated exacerbations in COPD by GOLD 1-4: A valid, robust, and seemingly low-biased definition." Respiratory medicine 109 (12) doi:10.1016/j.rmed.2015.10.015
Ingebrigtsen Truls S, Marott Jacob L, Rode Line, Vestbo Jørgen, Lange Peter, Nordestgaard Børge G 2015. "Fibrinogen and α1-antitrypsin in COPD exacerbations." Thorax 70 (11) doi:10.1136/thoraxjnl-2015-207561
Andrianopoulos Vasileios, Wouters Emiel F M, Pinto-Plata Victor M, Vanfleteren Lowie E G W, Bakke Per S, et al. 2015. "Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study." Respiratory medicine 109 (9) doi:10.1016/j.rmed.2015.06.013
Benson Victoria S, Müllerová Hana, Vestbo Jørgen, Wedzicha Jadwiga A, Patel Anant, Hurst John R 2015. "Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease." Respiratory medicine 109 (9) doi:10.1016/j.rmed.2015.06.009
Garrow Adam P, Khan Naimat, Tyson Sarah, Vestbo Jørgen, Singh Dave, Yorke Janelle 2015. "The development and first validation of the Manchester Early Morning Symptoms Index (MEMSI) for patients with COPD." Thorax 70 (8) doi:10.1136/thoraxjnl-2014-206410
Lange Peter, Celli Bartolome, Agustí Alvar, Boje Jensen Gorm, Divo Miguel, et al. 2015. "Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease." The New England journal of medicine 373 (2) doi:10.1056/NEJMoa1411532
Bihlet Asger R, Karsdal Morten A, Bay-Jensen Anne-Christine, Read Simon, Kristensen Jacob Hull, et al. 2015. "Clinical Drug Development Using Dynamic Biomarkers to Enable Personalized Health Care in COPD." Chest 148 (1) doi:10.1378/chest.15-0296
Holm Anne Trommelholt, Wulf-Johansson Helle, Hvidsten Svend, Jorgensen Patricia Troest, Schlosser Anders, et al. 2015. "Characterization of spontaneous air space enlargement in mice lacking microfibrillar-associated protein 4." American journal of physiology. Lung cellular and molecular physiology 308 (11) doi:10.1152/ajplung.00351.2014
Thomsen Laura H, Shaker Saher B, Dirksen Asger, Pedersen Jesper H, Tal-Singer Ruth, et al. 2015. "Correlation Between Emphysema and Lung Function in Healthy Smokers and Smokers With COPD." Chronic obstructive pulmonary diseases (Miami, Fla.) 2 (3) doi:10.15326/jcopdf.2.3.2014.0154
Wilke Sarah, Jones Paul W, Müllerova H, Vestbo Jørgen, Tal-Singer Ruth, et al. 2015. "One-year change in health status and subsequent outcomes in COPD." Thorax 70 (5) doi:10.1136/thoraxjnl-2014-205697
Vestbo Jørgen, Lange Peter 2015. "Prevention of COPD exacerbations: medications and other controversies." ERJ open research 1 (1) doi:10.1183/23120541.00011-2015
Müllerova Hana, Maselli Diego J, Locantore Nicholas, Vestbo Jørgen, Hurst John R, et al. 2015. "Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort." Chest 147 (4) doi:10.1378/chest.14-0655
Rennard Stephen I, Locantore Nicholas, Delafont Bruno, Tal-Singer Ruth, Silverman Edwin K, et al. 2015. "Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis." Annals of the American Thoracic Society 12 (3) doi:10.1513/AnnalsATS.201403-125OC
Çolak Yunus, Marott Jacob Louis, Vestbo Jørgen, Lange Peter 2015. "Overweight and obesity may lead to under-diagnosis of airflow limitation: findings from the Copenhagen City Heart Study." COPD 12 (1) doi:10.3109/15412555.2014.933955
Woodcock Ashley, Bakerly Nawar Diar, New John P, Gibson J Martin, Wu Wei, et al. 2015. "The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in asthma." BMC pulmonary medicine 15 doi:10.1186/s12890-015-0150-8
Bakerly Nawar Diar, Woodcock Ashley, New John P, Gibson J Martin, Wu Wei, et al. 2015. "The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in chronic obstructive pulmonary disease." Respiratory research 16 doi:10.1186/s12931-015-0267-6
Garrow Adam P, Yorke Janelle, Khan Naimat, Vestbo Jørgen, Singh Dave, Tyson Sarah 2015. "Systematic literature review of patient-reported outcome measures used in assessment and measurement of sleep disorders in chronic obstructive pulmonary disease." International journal of chronic obstructive pulmonary disease 10 doi:10.2147/COPD.S68093
Crim Courtney, Dransfield Mark T, Bourbeau Jean, Jones Paul W, Hanania Nicola A, et al. 2015. "Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD." Annals of the American Thoracic Society 12 (1) doi:10.1513/AnnalsATS.201409-413OC
Ingebrigtsen Truls S, Marott Jacob L, Nordestgaard Børge G, Lange Peter, Hallas Jesper, et al. 2015. "Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population." Journal of general internal medicine 30 (1) doi:10.1007/s11606-014-3029-0
Barnes Peter J, Burney Peter G J, Silverman Edwin K, Celli Bartolome R, Vestbo Jørgen, et al. 2015. "Chronic obstructive pulmonary disease." Nature reviews. Disease primers 1 doi:10.1038/nrdp.2015.76
Ingebrigtsen Truls S, Marott Jacob L, Nordestgaard Børge G, Lange Peter, Hallas Jesper, Vestbo Jørgen 2015. "Statin use and exacerbations in individuals with chronic obstructive pulmonary disease." Thorax 70 (1) doi:10.1136/thoraxjnl-2014-205795
Ingebrigtsen Truls S, Marott Jacob L, Vestbo Jørgen, Nordestgaard Børge G, Hallas Jesper, Lange Peter 2015. "Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease." Respirology (Carlton, Vic.) 20 (1) doi:10.1111/resp.12420

2014

Titlestad Ingrid Louise, Bryde Jonas, Øberg-Hansen Bo, Lassen Annmarie Touborg, Vestbo Jørgen 2014. "Reorganisation of acute referral to an emergency department resulted in fewer admissions for chronic obstructive pulmonary disease but in higher rates of non-invasive ventilation." Danish medical journal 61 (11) doi:
Vaes Anouk W, Garcia-Aymerich Judith, Marott Jacob L, Benet Marta, Groenen Miriam T J, et al. 2014. "Changes in physical activity and all-cause mortality in COPD." The European respiratory journal 44 (5) doi:10.1183/09031936.00023214
Janssen Daisy J A, Müllerova Hana, Agusti Alvar, Yates Julie C, Tal-Singer Ruth, et al. 2014. "Persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort." Respiratory medicine 108 (11) doi:10.1016/j.rmed.2014.07.013
McDonald Merry-Lynn N, Cho Michael H, Sørheim Inga-Cecilie, Lutz Sharon M, Castaldi Peter J, et al. 2014. "Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease." American journal of respiratory cell and molecular biology 51 (5) doi:10.1165/rcmb.2014-0135OC
Morgan Alexandra R, Parker Geoff J M, Roberts Caleb, Buonaccorsi Giovanni A, Maguire Niall C, et al. 2014. "Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPD." European journal of radiology 83 (11) doi:10.1016/j.ejrad.2014.08.004
Johansson Sofie Lock, Roberts Nassim Bazeghi, Schlosser Anders, Andersen Claus B, Carlsen Jørn, et al. 2014. "Microfibrillar-associated protein 4: a potential biomarker of chronic obstructive pulmonary disease." Respiratory medicine 108 (9) doi:10.1016/j.rmed.2014.06.003
Lumholdt Mads, Steenholt Janni Vagner, Vestbo Jørgen 2014. "[Inhaled corticosteroid treatment increases the risk of pneumonia in patients with CPOD.]" Ugeskrift for laeger 176 (36) doi:
Williams Michelle C, Murchison John T, Edwards Lisa D, Agustí Alvar, Bakke Per, et al. 2014. "Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality." Thorax 69 (8) doi:10.1136/thoraxjnl-2012-203151
Moberg Mia, Vestbo Jørgen, Martinez Gerd, Williams Johanna E A, Ladelund Steen, et al. 2014. "Validation of the i-BODE index as a predictor of hospitalization and mortality in patients with COPD participating in pulmonary rehabilitation." COPD 11 (4) doi:10.3109/15412555.2013.836171
Lange Peter, Marott Jacob Louis, Vestbo Jørgen, Ingebrigtsen Truls Sylvan, Nordestgaard Børge Grønne 2014. "Socioeconomic status and prognosis of COPD in Denmark." COPD 11 (4) doi:10.3109/15412555.2013.869580
Moberg Mia, Ringbaek Thomas, Roberts Nassim Bazeghi, Vestbo Jørgen 2014. "Association between vitamin D status and COPD phenotypes." Lung 192 (4) doi:10.1007/s00408-014-9582-9
Faner Rosa, Tal-Singer Ruth, Riley John H, Celli Bartolomé, Vestbo Jørgen, et al. 2014. "Lessons from ECLIPSE: a review of COPD biomarkers." Thorax 69 (7) doi:10.1136/thoraxjnl-2013-204778
Lange Peter, Marott Jacob Louis, Vestbo Jørgen, Nordestgaard Børge Grønne 2014. "Prevalence of night-time dyspnoea in COPD and its implications for prognosis." The European respiratory journal 43 (6) doi:10.1183/09031936.00196713
Johansson Sofie L, Tan Qihua, Holst René, Christiansen Lene, Hansen Niels C G, et al. 2014. "Surfactant protein D is a candidate biomarker for subclinical tobacco smoke-induced lung damage." American journal of physiology. Lung cellular and molecular physiology 306 (9) doi:10.1152/ajplung.00340.2013
Vestbo Jørgen, Vogelmeier Claus, Small Mark, Higgins Victoria 2014. "Understanding the GOLD 2011 Strategy as applied to a real-world COPD population." Respiratory medicine 108 (5) doi:10.1016/j.rmed.2014.03.002
Vestbo Jørgen, Agusti Alvar, Wouters Emiel F M, Bakke Per, Calverley Peter M A, et al. 2014. "Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team." American journal of respiratory and critical care medicine 189 (9) doi:10.1164/rccm.201311-2006PP
Vestbo Jørgen 2014. "COPD: definition and phenotypes." Clinics in chest medicine 35 (1) doi:10.1016/j.ccm.2013.10.010
Wedzicha Jadwiga, Vestbo Jørgen, Gallagher Nicola, Banerji Donald 2014. "A Novel Study Design for the Comparison Between Once-Daily QVA149 and Twice-Daily Salmeterol/Fluticasone on the Reduction of COPD Exacerbations: The FLAME Study." Chest 145 (3 Suppl) doi:10.1378/chest.1824340
Titlestad Ingrid L, Olsen Fanny, Sandqvist Hanna M, Pourbazargan Melvin M, Fretheim Håvard H, et al. 2014. "Are patients with COPD treated with NIV in accordance with national guidelines? An internal audit." European clinical respiratory journal 1 doi:10.3402/ecrj.v1.24506
Moberg Mia, Vestbo Jørgen, Martinez Gerd, Lange Peter, Ringbaek Thomas 2014. "Prognostic value of C-reactive protein, leukocytes, and vitamin d in severe chronic obstructive pulmonary disease." TheScientificWorldJournal 2014 doi:10.1155/2014/140736
Ravi Arjun K, Khurana Shruti, Lemon Jonathan, Plumb Jonathan, Booth George, et al. 2014. "Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum." Respiratory research 15 doi:10.1186/s12931-014-0103-4
Singh Dave, Nicolini Gabriele, Bindi Eddi, Corradi Massimo, Guastalla Daniele, et al. 2014. "Extrafine beclomethasone/formoterol compared to fluticasone/salmeterol combination therapy in COPD." BMC pulmonary medicine 14 doi:10.1186/1471-2466-14-43
Lock-Johansson Sofie, Vestbo Jørgen, Sorensen Grith Lykke 2014. "Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease." Respiratory research 15 doi:10.1186/s12931-014-0147-5

2013

Ingebrigtsen Truls S, Marott Jacob L, Vestbo Jørgen, Hallas Jesper, Nordestgaard Børge G, et al. 2013. "Characteristics of undertreatment in COPD in the general population." Chest 144 (6) doi:10.1378/chest.13-0453
Miller Joy, Edwards Lisa D, Agustí Alvar, Bakke Per, Calverley Peter M A, et al. 2013. "Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort." Respiratory medicine 107 (9) doi:10.1016/j.rmed.2013.05.001
Thomsen Mette, Nordestgaard Børge G, Vestbo Jørgen, Lange Peter 2013. "Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study." The Lancet. Respiratory medicine 1 (7) doi:10.1016/S2213-2600(13)70137-1
Snell Noel, Foster Martyn, Vestbo Jørgen 2013. "Efficacy and safety of AZD1981, a CRTH2 receptor antagonist, in patients with moderate to severe COPD." Respiratory medicine doi:10.1016/j.rmed.2013.06.006
Berg Isaac, Hanson Corrine, Sayles Harlan, Romberger Debra, Nelson Amy, et al. 2013. "Vitamin D, vitamin D binding protein, lung function and structure in COPD." Respiratory medicine doi:10.1016/j.rmed.2013.05.010
Agusti Alvar, Edwards Lisa D, Celli Bartolomé, Macnee William, Calverley Peter M A, et al. 2013. "Characteristics, stability and outcomes of the gold 2011 copd groups in the eclipse cohort." The European respiratory journal doi:10.1183/09031936.00195212
Thomsen Mette, Ingebrigtsen Truls Sylvan, Marott Jacob Louis, Dahl Morten, Lange Peter, et al. 2013. "Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease." JAMA : the journal of the American Medical Association 309 (22) doi:10.1001/jama.2013.5732
Agusti Alvar, Hurd Suzanne, Jones Paul, Fabbri Leonardo, Martinez Fernando, et al. 2013. "Frequently asked questions (FAQs) about the GOLD 2011 assessment proposal of COPD." The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology doi:10.1183/09031936.00036513
Dransfield Mark T, Bourbeau Jean, Jones Paul W, Hanania Nicola A, Mahler Donald A, et al. 2013. "Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials." The Lancet. Respiratory medicine 1 (3) doi:10.1016/S2213-2600(13)70040-7
Sumner Helen, Woodcock Ashley, Kolsum Umme, Dockry Rachel, Lazaar Aili L, et al. 2013. "Predictors of objective cough frequency in chronic obstructive pulmonary disease." American journal of respiratory and critical care medicine 187 (9) doi:10.1164/rccm.201211-2000OC
Rode Line, Bojesen Stig E, Weischer Maren, Vestbo Jørgen, Nordestgaard Børge G 2013. "Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals." Thorax 68 (5) doi:10.1136/thoraxjnl-2012-202544
Vestbo Jørgen, Anderson Julie, Brook Robert D, Calverley Peter M A, Celli Bartolome R, et al. 2013. "The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol." The European respiratory journal 41 (5) doi:10.1183/09031936.00087312
Vestbo Jørgen, Titlestad Ingrid L 2013. "[Medical treatment of COPD.]" Ugeskrift for laeger 175 (18) doi:
Coxson Harvey O, Dirksen Asger, Edwards Lisa D, Yates Julie C, Agusti Alvar, et al. 2013. "The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study." The Lancet. Respiratory medicine 1 (2) doi:10.1016/S2213-2600(13)70006-7
Jersild Jespersen Maria, Mygind Lone H, Vestbo Jørgen, Sonne Jesper 2013. "[Sparse effect of long-term treatment with macrolides in patients with chronic obstructive pulmonary disease]." Ugeskrift for laeger 175 (10) doi:
Polkey Michael I, Spruit Martijn A, Edwards Lisa D, Watkins Michael L, Pinto-Plata Victor, et al. 2013. "Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization." American journal of respiratory and critical care medicine 187 (4) doi:10.1164/rccm.201209-1596OC
Vestbo Jørgen, Hurd Suzanne S, Agustí Alvar G, Jones Paul W, Vogelmeier Claus, et al. 2013. "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary." American journal of respiratory and critical care medicine 187 (4) doi:10.1164/rccm.201204-0596PP
Loukides Stelios, Bartziokas Konstantinos, Vestbo Jørgen, Singh Dave 2013. "Novel anti-inflammatory agents in COPD: targeting lung and systemic inflammation." Current drug targets 14 (2) doi:
Singh Dave, Kampschulte Jorg, Wedzicha Jadwiga A, Jones Paul W, Cohuet Géraldine, et al. 2013. "A trial of beclomethasone/formoterol in COPD using EXACT-PRO to measure exacerbations." The European respiratory journal 41 (1) doi:10.1183/09031936.00207611
Titlestad Ingrid L, Lassen Annmarie T, Vestbo Jørgen 2013. "Long-term survival for COPD patients receiving noninvasive ventilation for acute respiratory failure." International journal of chronic obstructive pulmonary disease 8 doi:10.2147/COPD.S42632
Wulf-Johansson Helle, Lock Johansson Sofie, Schlosser Anders, Trommelholt Holm Anne, Rasmussen Lars Melholt, et al. 2013. "Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions." PloS one 8 (12) doi:10.1371/journal.pone.0082243
Sækmose Susanne Gjørup, Schlosser Anders, Holst René, Johansson Sofie Lock, Wulf-Johansson Helle, et al. 2013. "Enzyme-linked immunosorbent assay characterization of basal variation and heritability of systemic microfibrillar-associated protein 4." PloS one 8 (12) doi:10.1371/journal.pone.0082383
Rutten Erica P A, Calverley Peter M A, Casaburi Richard, Agusti Alvar, Bakke Per, et al. 2013. "Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes?" Annals of nutrition & metabolism 63 (3) doi:10.1159/000353211

2012

Kim Deog Kyeom, Cho Michael H, Hersh Craig P, Lomas David A, Miller Bruce E, et al. 2012. "Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease." American journal of respiratory and critical care medicine 186 (12) doi:10.1164/rccm.201206-1013OC
Eiken Pia A, Brask-Lindemann Dorte, Vestbo Jørgen, Langdahl Bente L, Abrahamsen Bo 2012. "[Diagnosing and treating osteoporosis in patients with chronic obstructive pulmonary disease]." Ugeskrift for laeger 174 (47) doi:
Lange Peter, Marott Jacob Louis, Vestbo Jørgen, Olsen Kim Rose, Ingebrigtsen Truls Sylvan, et al. 2012. "Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population." American journal of respiratory and critical care medicine 186 (10) doi:10.1164/rccm.201207-1299OC
Thomsen Mette, Dahl Morten, Lange Peter, Vestbo Jørgen, Nordestgaard Børge G 2012. "Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease." American journal of respiratory and critical care medicine 186 (10) doi:10.1164/rccm.201206-1113OC
Jensen Magnus Thorsten, Marott Jacob L, Lange Peter, Vestbo Jørgen, Schnohr Peter, et al. 2012. "Resting heart rate is a predictor of mortality in chronic obstructive pulmonary disease." The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology doi:10.1183/09031936.00072212
Colak Yunus, Løkke Anders, Marott Jacob Louis, Lange Peter, Vestbo Jørgen 2012. "Impact of diagnostic criteria on the prevalence of COPD." The clinical respiratory journal doi:10.1111/crj.12007
Vestbo Jørgen, Hurd Suzanne S, Rodriguez-Roisin Roberto 2012. "The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)--why and what?" The clinical respiratory journal 6 (4) doi:10.1111/crj.12002
Albert Paul, Agusti Alvar, Edwards Lisa, Tal-Singer Ruth, Yates Julie, et al. 2012. "Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease." Thorax 67 (8) doi:10.1136/thoraxjnl-2011-201458
Janner Julie Hjortsø, Godtfredsen Nina Skavlan, Ladelund Steen, Vestbo Jørgen, Prescott Eva 2012. "High aortic augmentation index predicts mortality and cardiovascular events in men from a general population, but not in women." European journal of preventive cardiology doi:10.1177/2047487312449588
Celli Bartolome R, Locantore Nicholas, Yates Julie, Tal-Singer Ruth, Miller Bruce E, et al. 2012. "Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease." American journal of respiratory and critical care medicine 185 (10) doi:10.1164/rccm.201110-1792OC
Vestbo Jørgen 2012. "[Telehealthcare for chronic obstructive pulmonary disease]." Ugeskrift for laeger 174 (14) doi:
Lange Peter, Marott Jacob Louis, Dahl Morten, Ingebrigtsen Truls Sulvan, Vestbo Jørgen, Nordestgaard Børge Grønne 2012. "Substantial need for early diagnosis, rehabilitation and treatment of chronic obstructive pulmonary disease." Danish medical journal 59 (4) doi:
Spruit Martijn A, Polkey Michael I, Celli Bartolome, Edwards Lisa D, Watkins Michael L, et al. 2012. "Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease." Journal of the American Medical Directors Association 13 (3) doi:10.1016/j.jamda.2011.06.009
Janner Julie H, McAllister David A, Godtfredsen Nina S, Prescott Eva, Vestbo Jørgen 2012. "Is chronic obstructive pulmonary disease associated with increased arterial stiffness?" Respiratory medicine 106 (3) doi:10.1016/j.rmed.2011.08.016
Cho Michael H, Castaldi Peter J, Wan Emily S, Siedlinski Mateusz, Hersh Craig P, et al. 2012. "A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13." Human molecular genetics 21 (4) doi:10.1093/hmg/ddr524
Verma Arpana, Harrison Annie, Torun Perihan, Vestbo Jørgen, Edwards Richard, Thornton Judith 2012. "Are pharmacists reducing COPD'S impact through smoking cessation and assessing inhaled steroid use?" Respiratory medicine 106 (2) doi:10.1016/j.rmed.2011.08.011
Al-shair Khaled, Muellerova Hana, Yorke Janelle, Rennard Stephen I, Wouters Emiel F M, et al. 2012. "Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale." Health and quality of life outcomes 10 doi:10.1186/1477-7525-10-100
Agustí Alvar, Edwards Lisa D, Rennard Stephen I, MacNee William, Tal-Singer Ruth, et al. 2012. "Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype." PloS one 7 (5) doi:10.1371/journal.pone.0037483

2011

Afzelius Pia, Bazeghi Nassim, Bie Peter, Bendtsen Flemming, Vestbo Jørgen, Møller Søren 2011. "Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension." Liver international : official journal of the International Association for the Study of the Liver 31 (9) doi:10.1111/j.1478-3231.2011.02576.x
Vestbo Jørgen, Edwards Lisa D, Scanlon Paul D, Yates Julie C, Agusti Alvar, et al. 2011. "Changes in forced expiratory volume in 1 second over time in COPD." The New England journal of medicine 365 (13) doi:10.1056/NEJMoa1105482
Agustí Alvar, Vestbo Jørgen 2011. "Current controversies and future perspectives in chronic obstructive pulmonary disease." American journal of respiratory and critical care medicine 184 (5) doi:10.1164/rccm.201103-0405PP
Bazeghi Nassim, Gerds Thomas A, Budtz-Jørgensen Esben, Hove Jens, Vestbo Jørgen 2011. "Exhaled nitric oxide measure using multiple flows in clinically relevant subgroups of COPD." Respiratory medicine 105 (9) doi:10.1016/j.rmed.2011.03.015
Yohannes Abebaw Mengistu, Willgoss Thomas George, Vestbo Jørgen 2011. "Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes." Respiratory care 56 (4) doi:10.4187/respcare.00852
Fabricius Peder, Løkke Anders, Marott Jacob Louis, Vestbo Jørgen, Lange Peter 2011. "Prevalence of COPD in Copenhagen." Respiratory medicine 105 (3) doi:10.1016/j.rmed.2010.09.019
Dahl Morten, Vestbo Jørgen, Zacho Jeppe, Lange Peter, Tybjærg-Hansen Anne, Nordestgaard Børge G 2011. "C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach." Thorax 66 (3) doi:10.1136/thx.2009.131193
Hanania Nicola A, Müllerova Hana, Locantore Nicholas W, Vestbo Jørgen, Watkins Michael L, et al. 2011. "Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort." American journal of respiratory and critical care medicine 183 (5) doi:10.1164/rccm.201003-0472OC
Jones Paul W, Anderson Julie A, Calverley Peter Ma, Celli Bartolome R, Ferguson Gary T, et al. 2011. "Health status in the TORCH study of COPD: treatment efficacy and other determinants of change." Respiratory research 12 doi:10.1186/1465-9921-12-71
Al-shair Khaled, Kolsum Umme, Dockry Rachel, Morris Julie, Singh Dave, Vestbo Jørgen 2011. "Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD." Respiratory research 12 doi:10.1186/1465-9921-12-3
Vestbo Jørgen, Anderson Julie Anne, Calverley Peter Mark Anthony, Celli Bartolomé, Ferguson Gary Thomas, et al. 2011. "Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH study." The clinical respiratory journal 5 (1) doi:10.1111/j.1752-699X.2010.00198.x

2010

Ingebrigtsen Truls, Thomsen Simon F, Vestbo Jørgen, van der Sluis Sophie, Kyvik Kirsten O, et al. 2010. "Genetic influences on Chronic Obstructive Pulmonary Disease - a twin study." Respiratory medicine 104 (12) doi:10.1016/j.rmed.2010.05.004
Sørheim Inga-Cecilie, Bakke Per, Gulsvik Amund, Pillai Sreekumar G, Johannessen Ane, et al. 2010. "α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts." Chest 138 (5) doi:10.1378/chest.10-0746
Eriksen Nanna, Vestbo Jørgen 2010. "Management and survival of patients admitted with an exacerbation of COPD: comparison of two Danish patient cohorts." The clinical respiratory journal 4 (4) doi:10.1111/j.1752-699X.2009.00177.x
Vestbo Jørgen, Vogelmeier Claus, Creemers Jacques, Falques Meritxell, Ribera Anna, Gil Esther Garcia 2010. "Onset of effect of aclidinium, a novel, long-acting muscarinic antagonist, in patients with COPD." COPD 7 (5) doi:10.3109/15412555.2010.510158
Hurst John R, Vestbo Jørgen, Anzueto Antonio, Locantore Nicholas, Müllerova Hana, et al. 2010. "Susceptibility to exacerbation in chronic obstructive pulmonary disease." The New England journal of medicine 363 (12) doi:10.1056/NEJMoa0909883
Han MeiLan K, Agusti Alvar, Calverley Peter M, Celli Bartolome R, Criner Gerard, et al. 2010. "Chronic obstructive pulmonary disease phenotypes: the future of COPD." American journal of respiratory and critical care medicine 182 (5) doi:10.1164/rccm.200912-1843CC
Kerstjens Huib A, Bjermer Leif, Eriksson Leif, Dahlström Kerstin, Vestbo Jørgen 2010. "Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patients." Respiratory medicine 104 (9) doi:10.1016/j.rmed.2010.04.010
Hersh Craig P, Pillai Sreekumar G, Zhu Guohua, Lomas David A, Bakke Per, et al. 2010. "Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene." American journal of respiratory and critical care medicine 182 (5) doi:10.1164/rccm.200910-1586OC
Calverley Peter M A, Anderson Julie A, Celli Bartolome, Ferguson Gary T, Jenkins Christine, et al. 2010. "Cardiovascular events in patients with COPD: TORCH study results." Thorax 65 (8) doi:10.1136/thx.2010.136077
Spruit Martijn A, Watkins Michael L, Edwards Lisa D, Vestbo Jørgen, Calverley Peter M A, et al. 2010. "Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort." Respiratory medicine 104 (6) doi:10.1016/j.rmed.2009.12.007
Janner Julie H, Godtfredsen Nina S, Ladelund Steen, Vestbo Jørgen, Prescott Eva 2010. "Aortic augmentation index: reference values in a large unselected population by means of the SphygmoCor device." American journal of hypertension 23 (2) doi:10.1038/ajh.2009.234
Lange Peter, Mogelvang Rasmus, Marott Jacob Louis, Vestbo Jørgen, Jensen Jan Skov 2010. "Cardiovascular morbidity in COPD: A study of the general population." COPD 7 (1) doi:10.3109/15412550903499506
Agusti Alvar, Calverley Peter M A, Celli Bartolome, Coxson Harvey O, Edwards Lisa D, et al. 2010. "Characterisation of COPD heterogeneity in the ECLIPSE cohort." Respiratory research 11 doi:10.1186/1465-9921-11-122

2009

Ferguson Gary T, Calverley Peter M A, Anderson Julie A, Jenkins Christine R, Jones Paul W, et al. 2009. "Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study." Chest 136 (6) doi:10.1378/chest.08-3016
Camp Pat G, Coxson Harvey O, Levy Robert D, Pillai Sreekumar G, Anderson Wayne, et al. 2009. "Sex differences in emphysema and airway disease in smokers." Chest 136 (6) doi:10.1378/chest.09-0676
Al-shair Khaled, Dockry Rachel, Mallia-Milanes Brendan, Kolsum Umme, Singh Dave, Vestbo Jørgen 2009. "Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD." Respiratory medicine 103 (10) doi:10.1016/j.rmed.2008.11.021
Sin Don D, Vestbo Jørgen 2009. "Biomarkers in chronic obstructive pulmonary disease." Proceedings of the American Thoracic Society 6 (6) doi:10.1513/pats.200904-019DS
Miller Martin R, Pedersen Ole F, Lange Peter, Vestbo Jørgen 2009. "Improved survival prediction from lung function data in a large population sample." Respiratory medicine 103 (3) doi:10.1016/j.rmed.2008.09.016
Kolsum Umme, Borrill Zoë, Roy Kay, Starkey Cerys, Vestbo Jørgen, et al. 2009. "Impulse oscillometry in COPD: identification of measurements related to airway obstruction, airway conductance and lung volumes." Respiratory medicine 103 (1) doi:10.1016/j.rmed.2008.07.014
Kolsum Umme, Roy Kay, Starkey Cerys, Borrill Zoë, Truman Nick, et al. 2009. "The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year." International journal of chronic obstructive pulmonary disease 4 doi:
Roy Kay, Smith Jacky, Kolsum Umme, Borrill Zöe, Vestbo Jørgen, Singh Dave 2009. "COPD phenotype description using principal components analysis." Respiratory research 10 doi:10.1186/1465-9921-10-41

2008

Rennard Stephen I, Vestbo Jørgen 2008. "Natural histories of chronic obstructive pulmonary disease." Proceedings of the American Thoracic Society 5 (9) doi:10.1513/pats.200804-035QC
Kirkham Sara, Kolsum Umme, Rousseau Karine, Singh Dave, Vestbo Jørgen, Thornton David J 2008. "MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease." American journal of respiratory and critical care medicine 178 (10) doi:10.1164/rccm.200803-391OC
Ingebrigtsen Truls, Thomsen Simon Francis, Vestbo Jørgen, Backer Vibeke 2008. "[Chronic obstructive pulmonary disease and genetics]." Ugeskrift for laeger 170 (38) doi:
Rennard Stephen I, Vestbo Jørgen 2008. "The many "small COPDs": COPD should be an orphan disease." Chest 134 (3) doi:10.1378/chest.07-3059
Patel Bipen D, Coxson Harvey O, Pillai Sreekumar G, Agustí Alvar G N, Calverley Peter M A, et al. 2008. "Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease." American journal of respiratory and critical care medicine 178 (5) doi:10.1164/rccm.200801-059OC
Celli Bartolomé R, Thomas Nicola E, Anderson Julie A, Ferguson Gary T, Jenkins Christine R, et al. 2008. "Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study." American journal of respiratory and critical care medicine 178 (4) doi:10.1164/rccm.200712-1869OC
Benfield Thomas, Lange Peter, Vestbo Jørgen 2008. "COPD stage and risk of hospitalization for infectious disease." Chest 134 (1) doi:10.1378/chest.07-2933

2007

Løkke Anders, Fabricius Peder G, Vestbo Jørgen, Marott Jacob Louis, Lange Peter 2007. "[Prevalence of chronic obstructive pulmonary disease in Copenhagen. Results from The Copenhagen City Heart Study]." Ugeskrift for laeger 169 (46) doi:
Vestbo Jørgen 2007. "[Salmeterol and fluticason and mortality in COPD patients]." Ugeskrift for laeger 169 (38) doi:
Corydon Thomas Juhl, Haagerup Annette, Jensen Thomas Gryesten, Binderup Helle Glud, Petersen Mikkel Steen, et al. 2007. "A functional CD86 polymorphism associated with asthma and related allergic disorders." Journal of medical genetics 44 (8) doi:10.1136/jmg.2007.049536
Fabricius Peder, Scharling Henrik, Løkke Anders, Vestbo Jørgen, Lange Peter 2007. "Exhaled CO, a predictor of lung function?" Respiratory medicine 101 (3) doi:10.1016/j.rmed.2006.06.013
Soriano Joan B, Sin Don D, Zhang Xuekui, Camp Pat G, Anderson Julie A, et al. 2007. "A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo." Chest 131 (3) doi:10.1378/chest.06-1696
Calverley Peter M A, Anderson Julie A, Celli Bartolome, Ferguson Gary T, Jenkins Christine, et al. 2007. "Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease." The New England journal of medicine 356 (8) doi:10.1056/NEJMoa063070
Dahl Morten, Vestbo Jørgen, Lange Peter, Bojesen Stig E, Tybjaerg-Hansen Anne, Nordestgaard Børge G 2007. "C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease." American journal of respiratory and critical care medicine 175 (3) doi:10.1164/rccm.200605-713OC

2006

Løkke Anders, Lange Peter, Vestbo Jørgen, Fabricius Peder G 2006. "[Developing COPD--25 years follow-up study of the general population]." Ugeskrift for laeger 168 (50) doi:
Godtfredsen Nina S, Prescott Eva, Vestbo Jørgen, Osler Merete 2006. "Smoking reduction and biomarkers in two longitudinal studies." Addiction (Abingdon, England) 101 (10) doi:10.1111/j.1360-0443.2006.01542.x
Vestbo Jørgen 2006. "Clinical assessment, staging, and epidemiology of chronic obstructive pulmonary disease exacerbations." Proceedings of the American Thoracic Society 3 (3) doi:10.1513/pats.200510-107SF
Christensen Ulla, Haagerup Annette, Binderup Helle G, Vestbo Jørgen, Kruse Torben A, Børglum Anders D 2006. "Family based association analysis of the IL2 and IL15 genes in allergic disorders." European journal of human genetics : EJHG 14 (2) doi:10.1038/sj.ejhg.5201541
Vestbo Jørgen, Prescott Eva, Almdal Thomas, Dahl Morten, Nordestgaard Børge G, et al. 2006. "Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study." American journal of respiratory and critical care medicine 173 (1) doi:10.1164/rccm.200506-969OC

2005

Peabody John W, Schau Brigitte, Lopez-Vidriero Maite, Vestbo Jørgen, Wade Sally, Iqbal Ahmar 2005. "COPD: a prevalence estimation model." Respirology (Carlton, Vic.) 10 (5) doi:10.1111/j.1440-1843.2005.00755.x
Juul Klaus, Tybjaerg-Hansen Anne, Mortensen Jann, Lange Peter, Vestbo Jørgen, Nordestgaard Børge G 2005. "Factor V leiden homozygosity, dyspnea, and reduced pulmonary function." Archives of internal medicine 165 (17) doi:10.1001/archinte.165.17.2032
Kiri Victor A, Pride Neil B, Soriano Joan B, Vestbo Jørgen 2005. "Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias." American journal of respiratory and critical care medicine 172 (4) doi:10.1164/rccm.200502-210OC
Pisinger Charlotta, Vestbo Jørgen, Borch-Johnsen Knut, Jørgensen Torben 2005. "It is possible to help smokers in early motivational stages to quit. The Inter99 study." Preventive medicine 40 (3) doi:10.1016/j.ypmed.2004.06.011
Pisinger Charlotta, Vestbo Jørgen, Borch-Johnsen Knut, Jørgensen Torben 2005. "Smoking cessation intervention in a large randomised population-based study. The Inter99 study." Preventive medicine 40 (3) doi:10.1016/j.ypmed.2004.06.001
Pisinger Charlotta, Vestbo Jørgen, Borch-Johnsen Knut, Jørgensen Torben 2005. "Smoking reduction intervention in a large population-based study. The Inter99 study." Preventive medicine 40 (1) doi:10.1016/j.ypmed.2004.05.014
Pisinger Charlotta, Vestbo Jørgen, Borch-Johnsen Knut, Thomsen Troels, Jørgensen Torben 2005. "Acceptance of the smoking cessation intervention in a large population-based study: the Inter99 study." Scandinavian journal of public health 33 (2) doi:10.1080/14034940410028370

2004

Vestbo Jørgen, Soriano Joan B, Anderson Julie A, Calverley Peter, Pauwels Romain, Jones Paul 2004. "Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD." Respiratory medicine 98 (11) doi:
Brasch-Andersen Charlotte, Christiansen Lene, Tan Qihua, Haagerup Annette, Vestbo Jørgen, Kruse Torben A 2004. "Possible gene dosage effect of glutathione-S-transferases on atopic asthma: using real-time PCR for quantification of GSTM1 and GSTT1 gene copy numbers." Human mutation 24 (3) doi:10.1002/humu.20074
Grønbaek Morten, Johansen Ditte, Becker Ulrik, Hein Hans Ole, Schnohr Peter, et al. 2004. "Changes in alcohol intake and mortality: a longitudinal population-based study." Epidemiology (Cambridge, Mass.) 15 (2) doi:
Dalsgareth Oli Jacob, Hansen Niels-Christian Gerner, Søes-Petersen Ulrik, Evald Torben, Høegholm Asbjørn, et al. 2004. "A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees." Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 6 (1) doi:10.1080/14622200310001656867
Müllerová Hana, Wedzicha Jadwiga, Soriano Joan B, Vestbo Jørgen 2004. "Validation of a chronic obstructive pulmonary disease screening questionnaire for population surveys." Respiratory medicine 98 (1) doi:

2003

Lange Peter, Parner Jan, Prescott Eva, Vestbo Jørgen 2003. "Chronic bronchitis in an elderly population." Age and ageing 32 (6) doi:
Eriksen Nanna, Hansen Ejvind Frausing, Munch Erik P, Rasmussen Finn Vejlø, Vestbo Jørgen 2003. "[Chronic obstructive pulmonary disease. Admission, course and prognosis]." Ugeskrift for laeger 165 (37) doi:
Ringbaek Thomas Jørgen, Eriksen Nanna, Vestbo Jørgen 2003. "[Assisted home care of patients with exacerbation of chronic obstructive pulmonary disease. Earlier discharge to treatment, monitoring and care at home led by a respiratory nurse]." Ugeskrift for laeger 165 (20) doi:
Calverley Peter, Pauwels Romain, Vestbo Jørgen, Jones Paul, Pride Neil, et al. 2003. "Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial." Lancet 361 (9356) doi:10.1016/S0140-6736(03)12459-2
Soriano Joan B, Kiri Victor A, Pride Neil B, Vestbo Jørgen 2003. "Inhaled corticosteroids with/without long-acting beta-agonists reduce the risk of rehospitalization and death in COPD patients." American journal of respiratory medicine : drugs, devices, and other interventions 2 (1) doi:

2002

Godtfredsen Nina S, Holst Claus, Prescott Eva, Vestbo Jørgen, Osler Merete 2002. "Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from The Copenhagen Centre for Prospective Population Studies." American journal of epidemiology 156 (11) doi:
Brøndum Eva, Lange Peter, Vestbo Jørgen 2002. "[Teenagers with asthma. A qualitative survey among teenagers with asthma of their expectations and attitudes when it comes to offered health care services]." Ugeskrift for laeger 164 (47) doi:
Dalsgarô Oli Jacob, Vestbo Jørgen 2002. "[Oxidative stress and genetic polymorphism in COPD]." Ugeskrift for laeger 164 (35) doi:
Hansen Jens Georg, Vestbo Jørgen 2002. "[Diagnosis and treatment in general practice of lower respiratory tract infections in adults]." Ugeskrift for laeger 164 (35) doi:
Vestbo Jørgen, Lange Peter 2002. "Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?" American journal of respiratory and critical care medicine 166 (3) doi:10.1164/rccm.2112048
Dahl Morten, Tybjaerg-Hansen Anne, Lange Peter, Vestbo Jørgen, Nordestgaard Børge G 2002. "Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population." Annals of internal medicine 136 (4) doi:
Vestbo Jørgen 2002. "Epidemiological studies in mucus hypersecretion." Novartis Foundation symposium 248 doi: